Levels of thrombin-antithrombin III complex in plasma in cases of acute promyelocytic leukemia. 1988

H Asakura, and M Saito, and K Ito, and Y Jokaji, and C Uotani, and I Kumabashiri, and T Matsuda
Department of Internal Medicine (III), Kanazawa University School of Medicine, Japan.

UI MeSH Term Description Entries
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D004211 Disseminated Intravascular Coagulation A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS. Consumption Coagulopathy,Coagulation, Disseminated Intravascular,Disseminated Coagulation, Intravascular,Intravascular Coagulation, Disseminated,Intravascular Disseminated Coagulation,Coagulation, Intravascular Disseminated,Coagulations, Disseminated Intravascular,Coagulations, Intravascular Disseminated,Coagulopathies, Consumption,Coagulopathy, Consumption,Consumption Coagulopathies,Disseminated Coagulations, Intravascular,Disseminated Intravascular Coagulations,Intravascular Coagulations, Disseminated,Intravascular Disseminated Coagulations
D005338 Fibrin Fibrinogen Degradation Products Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis. Antithrombin VI,Fibrin Degradation Product,Fibrin Degradation Products,Fibrin Fibrinogen Split Products,Degradation Product, Fibrin,Degradation Products, Fibrin,Product, Fibrin Degradation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000990 Antithrombin III A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily. Heparin Cofactor I,Antithrombin III-Alpha,Atenativ,Heparin Co-Factor I,Kybernin,Serpin C1,Thrombate III,Antithrombin III Alpha,Antithrombin IIIAlpha,Cofactor I, Heparin,Heparin Co Factor I
D013917 Thrombin An enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN. Thrombase,Thrombin JMI,Thrombin-JMI,Thrombinar,Thrombostat,alpha-Thrombin,beta,gamma-Thrombin,beta-Thrombin,gamma-Thrombin,JMI, Thrombin
D015470 Leukemia, Myeloid, Acute Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES. Leukemia, Myelogenous, Acute,Leukemia, Nonlymphocytic, Acute,Myeloid Leukemia, Acute,Nonlymphocytic Leukemia, Acute,ANLL,Acute Myelogenous Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia with Maturation,Acute Myeloid Leukemia without Maturation,Leukemia, Acute Myelogenous,Leukemia, Acute Myeloid,Leukemia, Myeloblastic, Acute,Leukemia, Myelocytic, Acute,Leukemia, Myeloid, Acute, M1,Leukemia, Myeloid, Acute, M2,Leukemia, Nonlymphoblastic, Acute,Myeloblastic Leukemia, Acute,Myelocytic Leukemia, Acute,Myelogenous Leukemia, Acute,Myeloid Leukemia, Acute, M1,Myeloid Leukemia, Acute, M2,Nonlymphoblastic Leukemia, Acute,Acute Myeloblastic Leukemia,Acute Myeloblastic Leukemias,Acute Myelocytic Leukemia,Acute Myelocytic Leukemias,Acute Myelogenous Leukemias,Acute Myeloid Leukemias,Acute Nonlymphoblastic Leukemia,Acute Nonlymphoblastic Leukemias,Acute Nonlymphocytic Leukemia,Acute Nonlymphocytic Leukemias,Leukemia, Acute Myeloblastic,Leukemia, Acute Myelocytic,Leukemia, Acute Nonlymphoblastic,Leukemia, Acute Nonlymphocytic,Leukemias, Acute Myeloblastic,Leukemias, Acute Myelocytic,Leukemias, Acute Myelogenous,Leukemias, Acute Myeloid,Leukemias, Acute Nonlymphoblastic,Leukemias, Acute Nonlymphocytic,Myeloblastic Leukemias, Acute,Myelocytic Leukemias, Acute,Myelogenous Leukemias, Acute,Myeloid Leukemias, Acute,Nonlymphoblastic Leukemias, Acute,Nonlymphocytic Leukemias, Acute

Related Publications

H Asakura, and M Saito, and K Ito, and Y Jokaji, and C Uotani, and I Kumabashiri, and T Matsuda
February 1993, Thrombosis research,
H Asakura, and M Saito, and K Ito, and Y Jokaji, and C Uotani, and I Kumabashiri, and T Matsuda
April 2001, Pediatrics international : official journal of the Japan Pediatric Society,
H Asakura, and M Saito, and K Ito, and Y Jokaji, and C Uotani, and I Kumabashiri, and T Matsuda
December 1988, Rinsho byori. The Japanese journal of clinical pathology,
H Asakura, and M Saito, and K Ito, and Y Jokaji, and C Uotani, and I Kumabashiri, and T Matsuda
January 2018, Digestive diseases (Basel, Switzerland),
H Asakura, and M Saito, and K Ito, and Y Jokaji, and C Uotani, and I Kumabashiri, and T Matsuda
February 1985, Blood,
H Asakura, and M Saito, and K Ito, and Y Jokaji, and C Uotani, and I Kumabashiri, and T Matsuda
November 1991, Scandinavian journal of gastroenterology,
H Asakura, and M Saito, and K Ito, and Y Jokaji, and C Uotani, and I Kumabashiri, and T Matsuda
July 1999, American journal of ophthalmology,
H Asakura, and M Saito, and K Ito, and Y Jokaji, and C Uotani, and I Kumabashiri, and T Matsuda
November 1998, American journal of ophthalmology,
H Asakura, and M Saito, and K Ito, and Y Jokaji, and C Uotani, and I Kumabashiri, and T Matsuda
November 1988, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
H Asakura, and M Saito, and K Ito, and Y Jokaji, and C Uotani, and I Kumabashiri, and T Matsuda
March 1995, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!